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Aims: The role of vascular smooth muscle endothelin A receptors (ETA) in development and normal physiology
remains incompletely understood. To address this, mice were generated with smooth muscle-speciﬁc knockout
(KO) of ETA.
Main methods: Mice were homozygous for loxP-ﬂanked exons 6–8 of the EDNRA gene (ﬂoxed) or were also
hemizygous for a transgene expressing Cre recombinase under control of the smooth muscle-speciﬁc SM22
promoter (KO mice).
Key ﬁndings: Genotyping at 17 days postnatal yielded a 10:1 ratio of ﬂoxed:KO mice. Smooth muscle actin
staining of embryos at day E10.5 revealed increased tortuosity in dorsal aortaewhile E12.5 embryos hadmandib-
ular, vascular and thymic abnormalities. Mice surviving to weaning developed and bred normally. ETA KOmice
aged 2–3 months manifested EDNRA gene recombination in all organs tested. Aortas from KO mice had a N90%
reduction in ETA mRNA content, but no differences in ET-1 or ETB mRNA levels. Addition of 0.01–100 nM ET-1
to isolated femoral arteries from ﬂoxed, but not KO, mice dose-dependently decreased vessel diameter (up to
80% reduction in the presence of ETB blockade). Intravenous infusion of ET-1 into ﬂoxed, but not KO, mice
increased mean arterial pressure (MAP) (by ~10 mm Hg). Telemetric analysis revealed decreased MAP in KO
mice (reduced by ~7–10 mm Hg) when fed a high salt diet.
Signiﬁcance: Smooth muscle ETA is important for normal vascular, mandibular and thymic development and is
involved in the maintenance of arterial pressure under physiological conditions.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Endothelin-1 (ET-1) was originally identiﬁed as a potent endotheli-
um derived vasoconstrictor peptide (Yanagisawa et al., 1988) though
now it is appreciated that a variety of tissues are able to produce ET-1
(Suzuki et al., 1989; Hama et al., 1997). ET-1 has been shown to mani-
festmost of its actionsdirectly through twoGprotein coupled receptors,
endothelin A and B receptors, which are differentially distributed
throughout many tissues (Nakamichi et al., 1992; Godfraind, 1993;
Karet et al., 1993). Because circulating plasma levels of ET-1 are too
low to activate its receptors (Battistini et al., 1993), it is thought that
local ET-1 production and signaling drive its effects. ET-1 signaling via
the ETA receptors in the vascular smooth muscle and kidney has beeniversity of Utah Health Sciences
81 2726; fax:+1801 5814343.
an).
. This is an open access article undershown to have an important regulatory role for both blood pressure
and blood ﬂow control in health and disease.
With the advent of whole body knock out (KO) mice, the develop-
mental importance of both ET-1 and ETA receptors has become appreci-
ated.Whole body KO of ET-1 alters cardiovascular development in both
the cardiac neural crest and larger arteries (Kurihara et al., 1995) and
several other less obvious areas such as the thyroid, thymus and crani-
al/facial structures (Kurihara et al., 1995). Furthermore, whole body
ETA KO mice appear to phenocopy these developmental defects
(Clouthier et al., 1998, 2000) indicating that ET-1 signaling thru the
ETA receptor is critical in the development of these tissues and organs.
Still, micewith a conditional KO of the ETA receptor in cardiacmyocytes
have not recapitulated these development defects (Kedzierski et al.,
2003) begging the question in which tissue is the ET-1 signaling via
ETA receptor necessary for appropriate development.
The goal of this study was, by using a Cre LoxP system to develop a
vascular smooth muscle speciﬁc conditional KO for the ETA receptor,
to: (1) characterize the vascular and hemodynamic effect of vascularthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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vascular ET-1 via ETA receptor signaling can phenocopy developmental
abnormalities seen in whole body KO models.Materials and methods
This investigation conforms with the Guide to the Care and Use of
Laboratory Animals (version 8, revised 2011) and was approved by the
University of Utah Animal Care and Use Committee.Animal model
Mouse breeding
Mice containing the loxP-ﬂanked (ﬂoxed) ETA receptor gene
(obtained from Dr. M. Yanagisawa at the Howard Hughes Institute at
University of Texas Southwestern Medical Center) were mated with
SM22-Cre mice. The ﬂoxed mice contain exons 6–8 of the ETA receptor
gene ﬂanked by loxP sites (these exons are critical to ETA receptor gene
functional expression) (Clouthier et al., 1998). The SM22-Cremouse has
been well characterized (Holtwick et al., 2002) and was obtained from
Jackson Labs (Bar Harbor, ME).Micewere bred to obtain ﬂoxed controls
(homozygous for the ﬂoxed ETA allele) or ETA KO (homozygous for
ﬂoxed ETA alleles and hemizygous for SM-22 Cre).Genotyping
Tail DNAwas prepared by standard methods and PCR was ampliﬁed
using RAF102F2 5′-CCCATGCTTAGACACAACCATG-3′ and ETA genoR2
5′-GATGACAACCAAGCAGAAGACAG-3′. These primers span the loxP
site upstream of exon 6. The wild-type allele product is 314 bp and
ﬂoxed allele is 354 bp. For SM22-Cre, tail DNA was ampliﬁed using SM
F: 5′-CAGACACCGAAGCTACTCTCCTTC C-3′ and SM R: 5′-CGCATAACCA
GTGAAACAGCATTG-3′ which yields a 600 bp product. PCR products
were visualized after electrophoresis through 1.5% agarose.Screening for recombination
DNA from various organs was PCR ampliﬁed to assess target organ
recombination using primers spanning exons 6–8 in the EDNRA gene:
F 5′-CCCATGCTTAGACACAACCATG-3′ and R 5′-CGCTGTTGTATATCCA
GTATCAGG-3′. Recombination of the EDNRA gene yields a 610 bp prod-
uct; the predicted size of the unrecombined EDNRA gene is 1287 bp and,
under the PCR conditions utilized, was not detectable.Developmental methods
Immunohistochemistry on tissue sections
Embryos were harvested at 12.5 DPC and ﬁxed in 20 volume zinc-
buffered formalin for 2 h at room temperature, followed by overnight
storage in 70% ethanol at 4 °C, and processing through graded alcohols
to parafﬁn. 5 μm transverse sections were collected to positively charged
glass slides and cured overnight at 42 °C. Following de-waxing and rehy-
dration, slides were re-ﬁxed in Methyl Carnoy's ﬁxative, washed and in-
cubated in 3% H2O2 to block endogenous peroxidases. Sections were
washed in PBS, blocked for 1 h in 1% BSA + 10% normal goat serum at
room temperature, followed by incubation in monoclonal anti-smooth
muscle alpha actin antibody (DAKO), in the presence of 1% BSA + 2%
normal goat serum, overnight at 4 °C. Slides were next washed in PBS
and incubated in a 1:200 dilution of HRP-conjugated goat anti-Mouse
IgG (Jackson Immunoresearch) for 1 h at room temperature, followed
by signal color development via DAB with hydrogen peroxide (Vector
Labs). Sections were counter-stained in Mayer hematoxylin and blued
in Scott's solution before dehydration andmountingwithCytoseal 60. Im-
ages were taken at 200×magniﬁcation on a Zeiss Axiophot2microscope,
equipped with a Zeiss Axiocam digital camera.Whole mount immunohistochemistry
Whole mount immunohistochemistry was carried out according to
the methods of Brigid Hogan et al. with minor modiﬁcations. Embryos
were dissected at 10.5 DPC and yolk sac fragments were retained for
PCR genotyping. Tissues were ﬁxed overnight in Dent's ﬁxative (4:1
MEOH:DMSO) at 4 °C, followed by bleaching in the same solution
by the addition of 1 part 37% H2O2 for 6–10 h at room temperature, and
storage at −20 °C in 100% MEOH. Embryos were rehydrated to PBS,
blocked/permeabilized for 3 h in PBSMT (PBS + 0.5% Triton X-
100 + 2% nonfat milk), and incubated overnight at 4 °C in the same
solutionwith the addition of 1:200monoclonal anti-mouse smoothmus-
cle alpha-actin (DAKO). Tissues were washed six times in PBSMT accord-
ing to protocol, and incubated overnight in PBSMT + 1:200 anti-Mouse
IgG HRP-conjugate (Jackson Immuno Research). Embryos were washed
six times again in PBSMT in the same manner, and incubated for 30 min
in 1 ml DAB + NiCl2 (Vector Labs) made up of PBT (PBS + 0.5%Triton
X-100 + 0.2% BSA). 37% H2O2 (1/1000 vol.) was added to develop signal
color. Peroxidase reaction was quenched by moving tissues to fresh PBT.
Tissues were post-ﬁxed in 4% paraformaldehyde overnight at 4 °C,
cleared with 1:2 benzyl alcohol:benzyl benzoate, and photographed on
a Leica MZ12 stereoscope equipped with a Zeiss Axiocam digital camera.
Vascular physiology phenotyping
In vitro isolated artery preparation
Normal chow fed mice were anesthetized (2–5% isoﬂurane) and eu-
thanized by exsanguination via cardiac puncture. The femoral artery
was excised from each leg and placed in cold (4 °C) physiological saline
solution (PSS) that contained 145.0 mM NaCl, 4.7 mM KCl, 2.0 mM
CaCl2, 1.17 mM MgSO4, 1.2 mM NaH2PO4, 5.0 mM glucose, 2.0 mM
pyruvate, 0.02 mM EDTA, 3.0 mMMOPS buffer and 1 g/100 ml BSA, at
pH 7.4 and surrounding tissueswere cleared from the artery as previous-
ly described (McCurdy et al., 2000; Muller-Delp et al., 2002a,b). Arteries
were placed in the bath of the pressure myograph (DMT) containing
MOPS-buffered PSS equilibrated to room air. Arteries were then cannu-
lated on both ends with micropipettes and secured with 11–0 surgical
nylon suture. After cannulation, the chambers were transferred to the
stage of an inverted microscope for recording of the luminal diameter
and pressurized to 50 mm Hg by two independent hydrostatic pressure
reservoirs (Durrant et al., 2009; Lesniewski et al., 2011; Donato et al.,
2013). Leaks were detected by pressurizing the vessel and then closing
the reservoirs to verify that the diameter remained constant. Arterioles
that did not maintain the diameter were discarded. Arterioles were then
warmed to 37 °C and allowed to equilibrate≥1 hprior to dose responses.
Lumen diameterwasmeasured prior to and after the cumulative addition
of ET-1 (10−11 to 10−7 M) in the presence of the ETB receptor antagonist
BQ-788 (1 μM, 1 h) to the surrounding bath. Vessels were allowed to
reach a steady state luminal diameter (~5 min) prior to the addition of
the next dose of ET-1. The second set of isolated arteries was frozen and
stored for ETA and ETB receptor mRNA analysis.
RNA analysis
RNA was isolated from aortas, and reverse transcribed and the
resulting DNA was assayed for relative expression of ETA mRNA
using the Taqman Gene Expression Assay (Applied Biosystems,
Carlsbad, CA, ETA probe cat# Mm01243722_m1, GAPDH probe cat#
Mm03302249_g1) as previously described (Donato et al., 2005).
Systemic ET-1 vasopressor responsiveness
Mice (n = 8 per group) were surgically implanted with a carotid te-
lemetry device (TA11-PAC10, Data Sciences International, St. Paul, MN)
to monitor conscious blood pressures and allowed to recover at least
3 days prior to ET-1 study. On the day of the study, mice were anesthe-
tized with 2% inhaled isoﬂurane and an indwelling jugular vein catheter
(Micro-renathane 0.025″ O.D. × 0.012″ I.D., Braintree Scientiﬁc Inc.,
Braintree, MA, USA) was implanted. While maintained under anesthesia,
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150 μl bolus of sterile saline was then infused via the jugular catheter
and blood pressure was recorded continuously for 3 min and averaged
over each minute. Mean arterial pressure during saline infusion was not
different from pre-saline infusion and was therefore used as baseline
blood pressure in the analyses. Following blood pressure monitoring
after saline infusion, a 150 μl bolus injection containing 0.1 nmol/kg ET-
1was administered via the jugular catheter and blood pressurewasmon-
itored continuously for 15 min andminute averageswere calculated. Fol-
lowing 15 min of blood pressure monitoring, the mouse was euthanized
by bilateral thoracotomy while under isoﬂurane anesthesia. The peak
blood pressure response to ET-1 was used in the analysis.
Pressor effects of high sodium diet
Blood pressure was recorded via telemetry. Mice aged ~3 months
were anesthetized with 2% isoﬂurane, implanted with a radio transmit-
ter and allowed to recover in individual cages for 5 days. Automated
blood pressure and heart rate were recorded continuously thereafter
with measurements taken every 10 min. Animals were maintained on
a normal Na+ diet (0.15% Na+) or high Na+ diet (3.2% Na+). Mice
were not handled during blood pressure recording periods since even
small stimuli markedly affect blood pressure.
Data presentation and statistical analysis
For in vitro vascular reactivity to ET-1, vasoconstrictor responses
were recorded as actual diameters and expressed as a percentage of
possible constriction according to the formula:
Vasoconstriction %Maximal Responseð Þ ¼ DB−DSð Þ=DB½   100%
where DS is the steady-state inner diameter recorded after each dose
and DB is the initial baseline inner diameter before the ﬁrst addition of
ET-1. Sensitivity (EC50) was calculated by ﬁtting a sigmoidal curve at
the dose response data using BioDataFit 1.02.
Repeated measures (RM) ANOVAs were used to determine the
signiﬁcance of differences between genotypes for dose responses in iso-
lated arteries and for MAP, SBP, DBP and HR measured by telemetry in
normal chow and high salt fed mice. Student's t-tests were performed
to detect group differences for all other analyses including post hoc
analyses. All data are presented as mean ± S.E.M. Signiﬁcance was set
at P ≤ 0.05.
Results
Conﬁrmation of smooth muscle ETA KO
DNA recombination occurred in all tissues assessed from the SM22-
Cre/ﬂoxed ETA mice (Fig. 1A) and was associated with an almost total0
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Fig. 1. Conﬁrmation of successful deletion of smoothmuscle endothelin A receptors (SM-ETA) in
mice. Representative of data from5mice of each genotype.mRNA expression (B) of ETA, endoth
mice (N = 5/genotype). * P ≤ 0.05 vs. ﬂoxed.loss of ETA in aortas of the ETA KO mice compared to ﬂoxed controls
(Fig. 1B). This deletion of ETA was speciﬁc to the ETA isoform, as there
was no concomitant reduction in either ETB or ET-1mRNA in the aortas
of the SM-ETA KO mice (Fig. 1B).
Developmental effects of smooth muscle ETA deletion
Compared to the ﬂoxed control mice, SM-ETA KO mice demonstrat-
ed an irregular smooth muscle cell investment in the pharyngeal arch
region with tortuosity evident at E10.5 (Fig. 2A). By day E12.5, SM-
ETA KO embryos were growth retarded (Fig. 2B) with reduced crown
to rump length (Fig. 2C). Mandibularmal-development and cranial vas-
cularmalformations (Fig. 2D) in the SM-ETA KOmice were also evident
by E12.5, and were concomitant with defective thymic processes, peri-
cardial cystic space and thickened aortic arch vessels (Fig. 2D). In addi-
tion to these developmental defects, the SM-ETAKOmice demonstrated
decreased viability such that there were only 29 SM-ETA KO offspring
compared to 202 homozygous ﬂoxed ETA mice surviving to at least
postnatal day 17 from a homozygous ﬂoxed ETA/heterozygous SM22-
Cre transgenic (smooth muscle ETA KO). In adult mice, there were no
differences in the body, heart, liver, gastrocnemius muscle, epididymal
white adipose tissue mass or blood glucose concentrations (Table 1).
ET-1-mediated vasoconstriction/vasopressive responses
In the presence of the ETB receptor antagonist BQ-788, the dose re-
sponse to ET-1 andmaximal ET-1 induced vasoconstrictionwas blunted
~60% (P = 0.01) in the SM-ETAKOmice comparedwith ﬂoxed controls
(Fig. 3A). Sensitivity (EC50) to ET-1 did not differ between groups
(Fig. 3A).Maximal diameter of the isolated, pressurized femoral arteries
did not differ between SM-ETA KO and ﬂoxed control mice (Fig. 3B).
Although baseline anesthetized mean arterial pressure did not differ
between SM-ETA KO and ﬂoxed mice, in response to infusion of ET-1
in the intact animal, ET-1 elicited an increase in mean arterial pressure
(P b 0.01) that was absent in the SM-ETA KO mice (Fig. 3C).
Responses to hemodynamic stressor of high salt diet
Measured in home cages by telemetry, there were no differences in
mean, systolic and diastolic blood pressure or pulse rate between ﬂoxed
control and SM ETA KO mice in the four days prior to dietary salt load-
ing. After increased dietary salt intake, mean (Fig. 4A), systolic
(Fig. 4B) and diastolic (Fig. 4C) blood pressurewere higher in the ﬂoxed
control mice compared with SM-ETA KO mice (all P b 0.05) and this
effect largely persisted over 7 days of high dietary salt. Although not
different when fed normal chow, when compared with ﬂoxed control
mice, pulse rate was higher in SM-ETA KO mice after 1, 6 and 7 days
of high dietary salt (Fig. 4D).ETA ETB ET-1
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Fig. 2. Developmental defects in smooth muscle endothelin A receptor knockout (SM-ETA KO) mice. At E10.5, SM-ETA KO mice demonstrate an (A) irregular smooth muscle cell
investment of dorsal aortic anlagen in the pharyngeal arch region with tortuosity, demonstrated by alpha AM actin whole mount immunohistochemistry (N = 3/genotype).
Bar = 1 mm. SM-ETA KO have retarded (B) growth quantiﬁed as reduced (C) crown-rump length compared to ﬂoxed control mice as well as (D) mandibular mal-development (blue
arrows) and cranial vascular malformations (green arrow). At alpha smoothmuscle actin stained transverse sections of embryos E12.5 demonstrate defective thymic processes (T, absent
in SM-STA KO), and enlarged pericardial cavity (orange *), jugular vein (J) and thickened aortic arch (Ao A) vessels (N = 3/genotype). * P ≤ 0.05 vs. ﬂoxed.
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Our results demonstrate that smooth muscle targeting of the Ednra
gene utilizing a SM22-Cre and loxPﬂanking of the ETA receptor resulted
in successful smooth muscle speciﬁc deletion of the ETA receptor in
mice. Furthermore, this smooth muscle speciﬁc ETA receptor deletion
results in blunted hemodynamic ET-1 vasoconstriction measured both
in vitro (isolated arteries) and in vivo (via blood pressure). Salt-
sensitive increases in blood pressure are dependent on an intact smooth
muscle ETA receptor, as it was prevented in the smooth muscle ETA KO
mice but not ﬂoxed control mice. Finally, our ﬁndings also provide
broad insight into the importance of smooth muscle ET-1 signaling
through the ETA receptor in the development as our smooth muscle
speciﬁc ETA receptor KO phenocopied whole body ETA receptor
KO and ET-1 KO mice with decreased survival and developmental
abnormalities in the cardiovascular system, thymus and mandible. Our
ﬁndings suggest that these developmental abnormalities are the result
of the abolished ET-1 signaling through the ETA receptor in the vascular
smooth muscle and not other tissues.
Hemodynamic effects of smooth muscle deletion of ETA receptors
Dysregulation of ET-1 and its signaling through the ETA receptor has
been implicated in disrupted hemodynamic and vascular homeostasisTable 1
Body and tissue masses for ﬂoxed control and smooth muscle endothelin receptor A
knockout (SM-ETA KO) mice.
Floxed SM-ETA KO
Body mass (g) 32 ± 2 31 ± 3
Blood glucose (mg/dl) 135 ± 10 132 ± 9
Heart mass (g) 0.20 ± 0.03 0.16 ± 0.03
Liver mass (g) 1.75 ± 0.20 1.67 ± 0.14
Gastrocnemius muscle mass (g) 0.27 ± 0.04 0.29 ± 0.06
Epididymis adipose tissue (g) 0.68 ± 0.17 0.70 ± 0.09
Data are means ± SEM.in a multitude of cardiovascular diseases, kidney disease and advanced
age (Koyama et al., 1989; Zoccali et al., 1995; Rossi et al., 1999;
Schiffrin, 1999; Ihling et al., 2001; Donato et al., 2009; Seals et al.,
2011). While numerous studies have been conducted on arterial
vasoreactivity and hemodynamic responses of ET-1/ETA signaling via
pharmacological blockade of the ETA receptors (Maguire and
Davenport, 1995; Spratt et al., 2001; Donato et al., 2005), no smooth
muscle speciﬁc genetic models had been created to date. Our data sug-
gests that, utilizing a Cre recombinase on the SM22 promoter, we have
successfully created a conditional smooth muscle ETA receptor knock
out mouse. Our novel model supports the role of the vascular smooth
muscle ETA receptor in inducing a vast majority of ET-1-induced vaso-
constriction measured in vitro in isolated arteries as well as in the in-
duction of the vasopressor response to in vivo ET-1 infusion. These
results are consistentwith numerous prior studies that utilized pharma-
cological ETA antagonists in vitro and in vivo in health and disease
(Iglarz et al., 1998; Spratt et al., 2001; Cowburn et al., 2005). Finally,
we aimed to determine if salt-dependent increases in blood pressure, al-
beit modest in the C57BL6 mouse strain, involved the ETA receptor.
Here, we demonstrate that smooth muscle deletion of the ETA receptor
abrogated the blood pressure response to a high salt diet compared to
the ﬂoxed controls. These results are consistent with pharmacological
blockade of the ETA receptor (Okada et al., 1994; d'Uscio et al., 1997).
In summary, we have demonstrated that our smooth muscle ETA
knock out faithfully displays a hemodynamic proﬁle that is consistent
with the established role of ETA signaling in response to ET-1 exposure
and dietary stressors. Thus, this mouse model provides an alternate ap-
proach that may be employed to better understand ET-1/ETA signaling
when pharmacological blockade is not a viable scientiﬁc option or
when isolating smoothmuscle speciﬁc effects from other tissue is of ut-
most importance.
Developmental effect of smooth muscle deletion of ETA receptors
Until recently, the importance of ET-1 signaling through the
ETA receptor was not appreciated. With the advent of whole body
ET-1 [log M]
Pre -11 -10 -9 -8 -7
Va
so
co
ns
tri
ct
io
n 
(%
)
-20
0
20
40
60
80 Floxed
SM-ETA KO
Floxed SM-ETA KO
M
AP
 (m
mH
g)
0
20
75
80
85
90
95
Baseline
ET1 
*
*
BA
EC50 [log M]
Floxed: -8.8 ±0.3
SM-ETA KO: -9.8 ±0.7
†
C
Floxed SM-ETA KO
M
ax
im
al
 F
em
or
al
 A
rte
ry
 
D
ia
m
et
er
 (µ
m
)
0
100
200
300
400
500
Fig. 3. Endothelin-1 mediated vasoconstriction is absent in smooth muscle endothelin receptor A knockout (SM-ETA KO) mice. Dose response to endothelin-1 (A) in the presence of the
endothelin receptor B antagonist, BQ-788, in isolated femoral arteries from SM-ETA KO and ﬂoxed control mice. Sensitivity (EC50) to ET-1 is presented in the inset. Maximal femoral artery
luminal diameter (B) measured in vitro (N = 5/genotype). * P ≤ 0.05 vs. ﬂoxed for dose response by RM-ANOVA, † P ≤ 0.05 vs. ﬂoxed for maximal vasodilation by student's t-test. Peak
mean arterial pressure (C) in response to bolus infusion of saline (baseline, monitored 3 min post infusion) or endothelin-1 (ET1, monitored 15 min post infusion) in SM-ETA KO and
ﬂoxed control mice (N = 3–6/genotype). * P ≤ 0.05 vs. ﬂoxed.
242 A.J. Donato et al. / Life Sciences 118 (2014) 238–243genetically altered mice it has been subsequently shown that this path-
way is of critical importance in the normal development of several or-
gans and the arterial network (Kurihara et al., 1995; Clouthier et al.,
1998; Yanagisawa et al., 1998). Furthermore, it became evident that
whole body deletion of either of these components of the endothelin
system resulted in increased embryonic mortality compared to wild
type mice (Kurihara et al., 1994; Clouthier et al., 1998). Notably, endo-
thelial cell-speciﬁc ET-1 deletion does not cause developmental abnor-
malities, suggesting that ET-1 from non-endothelial cell sources can
maintain normal vascular development (Kisanuki et al., 2010). These
studies established a critical role for ET-1 signaling through the ETA re-
ceptor in viable embryonic development as well as the role of ET-1/ETA
receptor signaling in development of critical tissues such as the thymus
and arterial system. Still, due to the ubiquitous production of ET-1 and
its ETA receptor in tissues, it was unclear what tissue was critical for
these developmental effects (Nakamichi et al., 1992; Godfraind, 1993;
Karet et al., 1993). Our model of smooth muscle speciﬁc ETA receptor
deletion phenocopies the developmental defects previously demon-
strated inwhole body knock outmodels, i.e. that there is abnormal arte-
rial network development, mandibular development and defectiveDays
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pups from each litter were vastly skewed to the wild type versus
knock out, suggesting that smooth muscle deletion of the ETA receptor
yields a lower than the expectedMendelian ratio of viable pups. This is a
likely consequence of the abnormal embryonic aortic arch development
previously described (Kurihara et al., 1995; Yanagisawa et al., 1998).
Still, smooth muscle ETA knockout mice that survived and matured
had a grossly normal appearance and normal growth. While not the in-
tent of the study, we speculate that mice that survived to adulthood
likely had some difference in ETA expression during development, yet
had complete vascular ETA knockout in adulthood — it is possible that
the timing of ETA knockout was slightly later in these surviving mice.
Taken together, our results suggest that vascular smoothmuscle speciﬁc
ET-1/ETA signaling is a critical pathway in vascular, mandibular, neural
crest and thymus development. Therefore, the deletion of pathway
components reduces embryonic viability. Importantly, the emergence
of these phenotypes suggests that this mouse model may be useful for
research related to human diseases such as velocardiofacial syndrome
and/or DiGeorge syndrome (Kurihara et al., 1995; Clouthier et al.,
1998; Kobrynski and Sullivan, 2007).Days
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In the present study we sought to validate and characterize the
developmental and hemodynamic consequences of vascular smooth
muscle ETA receptor deletion. We focused on establishing evidence of
smooth muscle ETA receptors via whole aorta RT-PCR for mRNA and
femoral vascular responsiveness to ET-1 in the presence of an ETB
receptor antagonist. While there were drastic reductions in both ETA
receptor mRNA and vasoconstriction, some residual expression and
vasoconstriction were observed. We attribute the minimal amounts of
ETA mRNA to non-vascular smooth muscle cells within the arterial
wall (i.e. mast cells, ﬁbroblasts and resident immune cells) that exhibit
ETA receptors. To minimize the effects of ETB-mediated vasoconstric-
tion masking differences in the ET-1 mediated vasoconstriction be-
tween control and ETA KO mice, we chose to perform the isolated
artery dose responses in the presence of ETB inhibition. Nevertheless,
it is likely that the small amount of residual vasoconstriction observed
in the femoral arteries at very high doses of ET-1 is due to ET-1 out-
competing the ETB antagonist for the ETB receptor. It is well known
that at supraphysiological levels of ET-1 it is difﬁcult to completely
block all the vascular smooth muscle ETB receptors. An alternative ex-
planation would be that we have only knocked down the vascular
smooth muscle ETA receptor, but with the genetic technology utilized
it is far more likely that our results are due to the aforementioned tech-
nical limitations. Next, we did not extensively explore alterations of ETB
receptors or examine the sympathetic nervous system in this model. It
may be that vascular smooth muscle ETB receptors and sympathetic
nervous systemoutﬂoware altered; future studies should better pheno-
type the compensatory physiological mechanisms whichmay compen-
sate for the deletion of vascular smooth muscle ETA receptors during
development.
Conclusions
In conclusion, this novel animalmodel provides direct evidence for a
speciﬁc role of the smooth muscle ETA receptor in embryonic develop-
ment and vascular reactivity. Speciﬁcally, we demonstrate that smooth
muscle ETA receptors are essential for normal embryonic development
and that, in mature animals, the ETA receptor in the smooth muscle is
essential for normal ET-1 mediated vasoconstriction, as well as for the
induction of elevated blood pressure in response to high dietary salt in-
take. This novel mouse model will provide yet another tool in the
endothelin researchers' armamentarium yielding greater understand-
ing of this pathway in neonatal development, healthy physiological
function and the pathology of disease.
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